The week in health tech, explained in plain English.Get the free newsletter →
October 24, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Government

FDA Approves Bemotrizinol, First New Sunscreen Filter in 25 Years

The FDA on Tuesday approved bemotrizinol, the first new sunscreen ingredient cleared for the U.S. market in more than 25 years, STAT News reported. The decision ends a long stretch in which American consumers had access to far fewer ultraviolet filters than people in Europe and Asia, where bemotrizinol has been used for years.

The ingredient, also known commercially as Tinosorb S, absorbs both UVA and UVB rays. Its arrival could give U.S. manufacturers a new tool to formulate broad-spectrum products, an area where domestic options have lagged because of the slow regulatory path for sunscreen actives.

Sunscreen ingredients in the U.S. are regulated as over-the-counter drugs, which has made approvals far slower than the cosmetic-style review used abroad. The bemotrizinol clearance signals movement on a backlog that dermatologists and industry groups have pressed the agency to address, potentially opening the door for additional filters already common overseas.

Sources

More in Government

Government

FDA Approves First Once-Weekly Insulin for Children

The FDA approved Novo Nordisk's Awiqli, the first once-weekly basal insulin for children 10 and older with Type 2 diabetes.

Why it matters: Weekly rather than daily insulin could improve adherence for a growing number of children with Type 2 diabetes.

Government

Feds Launch False Claims Act Self-Disclosure Pilot

HHS and the DOJ Civil Division have launched a six-month pilot letting healthcare companies self-report potential civil False Claims Act violations and settle through a coordinated civil release.

Why it matters: The pilot reshapes how hospitals and healthcare firms weigh self-reporting against federal fraud enforcement, with real consequences for compliance strategy.

Government

GOP Pushes Fraud Message to Deflect Healthcare Cost Anger

Republicans are elevating healthcare fraud as a midterm message to deflect voter anger over costs, while Democrats say the push targets blue states to justify Medicaid and ACA cuts.

Why it matters: Fraud-focused enforcement could reshape Medicaid and ACA funding, audits, and eligibility for the tens of millions who depend on those programs.